One of the earliest Alzheimer's and Parkinson's signs that happens 'decades before'
People with Alzheimer's and Parkinson's disease may experience loss of smell long before other symptoms appear. One of the ...
This Brain Disease Is Set To Double Worldwide By 2050. Are We Prepared? What Scientists Say.
In the study, which was published in The BMJ, researchers analyzed data from 195 countries and territories using the 2021 ...
Scientists solve decades-long Parkinson’s mystery
Researchers at the WEHI Parkinson’s Disease Research Centre have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery. In a major breakthrough, they have ...
Portable AI system helps detect cognitive impairment
Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with ...
New discovery as to what causes Parkinson’s disease
One of the world’s leading Parkinson’s disease scientists has warned of a potential pandemic of the neurological condition if ...
MyChesCo on MSN9h
Annovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development Summit
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development ...
Annovis Joins Experts at Drug Development Summit to Redefine Parkinson's Treatment
Annovis Bio Inc. (NYSE: ANVS) ("Annovis"), a late-stage clinical drug platform company pioneering transformative therapies ...
Discover Magazine on MSN23h
Rosemary and Sage Could Lead to Better Alzheimer’s Treatment
Discover how a natural compound found in these common herbs could enhance cognitive function and ease inflammation.
TechBullion1h
Disease Modifying in Neurodegenerative Disease Treatment: An Interview with Alon Ben-Noon, CEO & Founder of NeuroSense Therapeutics
Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...